awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38361928-CA8A1148-6DBD-4252-8608-7980F7E3E800
Q38361928-CA8A1148-6DBD-4252-8608-7980F7E3E800
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38361928-CA8A1148-6DBD-4252-8608-7980F7E3E800
Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer.
P2860
Q38361928-CA8A1148-6DBD-4252-8608-7980F7E3E800
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38361928-CA8A1148-6DBD-4252-8608-7980F7E3E800
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cbc48bae26efee980b0c1d959f749b0c3c4eb66b
P2860
Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.